Summit Securities Group
CVS icon

Summit Securities Group’s CVS Health CVS Stock Holding History

Summit Securities Group’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-48,300
Closed -$3.27M – 1148
2025
Q1 		$3.27M Buy
+48,300
New +$2.89M 0.51% 22
2022
Q2 		– Sell
-86,300
Closed -$8.73M – 1001
2022
Q1 		$8.73M Sell
86,300
-140,000
-62% -$14.7M 0.98% 15
2021
Q4 		$23.3M Buy
226,300
+226,232
+332,694% +$20.9M 1.09% 14
2021
Q3 		$577K Sell
68
-90
-57% -$7.54K 0.04% 367
2021
Q2 		$1.32M Sell
158
-142
-47% -$11.6K 0.11% 201
2021
Q1 		$2.26M Sell
300
-97
-24% -$7.07K 0.25% 85
2020
Q4 		$2.71M Buy
397
+181
+84% +$11.8K 0.23% 113
2020
Q3 		$1.26M Buy
216
+20
+10% +$1.24K 0.13% 131
2020
Q2 		$1.27M Sell
196
-150
-43% -$9.45K 0.16% 129
2020
Q1 		$2.05M Buy
+346
New +$23.1K 0.36% 64
2019
Q1 		– Sell
-84
Closed -$550K – 228
2018
Q4 		$550K Buy
+84
New +$6.27K 0.05% 194

Other funds holding CVS

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Capital World Investors
Capital World Investors Los Angeles, California $824B AUM 37.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $187B AUM 13.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $704B AUM 26.74% 1-Year Est. Return

Summit Securities Group's CVS Position: Q3 2026 in Review

Summit Securities Group increased its CVS Health (CVS) stake by 471% in Q3 2026, buying an estimated $413K and bringing the position to 5,116 shares worth $438K. The position accounts for 0.04% of the portfolio, ranked #194.

Summit Securities Group first reported a position in CVS in Q2 2013 and has held it in 40 quarters since. The position peaked at $10.1M in Q4 2021. 1,724 funds tracked by Wall St. Rank hold CVS as of Q3 2026.

  • Summit Securities Group held 5,116 shares of CVS Health worth $438K as of Q3 2026.
  • Summit Securities Group bought 4,220 CVS Health shares in Q3 2026, an estimated $413K.
  • CVS Health made up 0.04% of Summit Securities Group's portfolio in Q3 2026, its #194 holding.
  • Summit Securities Group first reported a position in CVS Health in Q2 2013 and has held it in 40 quarters since.
  • Summit Securities Group's CVS Health position peaked at $10.1M in Q4 2021.
  • 1,724 funds tracked by Wall St. Rank held CVS Health as of Q3 2026.

Based on Summit Securities Group's 13F filing for Q3 2026, filed 5 Nov 2026.